![]() |
![]() |
![]() |
![]() |
LB eP-001 | Vascular jump graft from superior mesenteric vein for inflow in living donor liver transplantation | Basant Mahadevappa | ![]() |
![]() |
|||
eP-001 | Right anterior section graft for living donor liver transplantation | Jonathan Navarro | ![]() |
![]() |
|||
eP-002 | Robotic donor hepatectomy | Biju Chandran | ![]() |
![]() |
|||
LB eP-002 | Hot Hydrodissection in a case of redo liver transplantation Surgical Video Presentation | Unal Aydin | ![]() |
![]() |
|||
P-002 | Improvement in risk category for liver transplant candidacy in patients with portopulmonary hypertension treated with macitentan: a post-hoc analysis from the PORTICO study | Richard McDonald | ![]() |
![]() |
|||
LB P-002 | Rhabdomyolysis as an unusual contributor to lactic acidosis after pediatric liver transplantation for hepatopulmonary syndrome: a case report | Mali Hetmaniuk | ![]() |
![]() |
|||
LB P-003 | Cognitive aid and clinical guide for safe and efficient intraoperative use of transesophageal echocardiography (TEE) during liver transplant | Nelson Gonzalez | ![]() |
![]() |
|||
eP-003 | in situ Liver Splitting for Pediatric and Adult Liver Transplantation | Petru Bucur | ![]() |
![]() |
|||
LB eP-003 | Do we need patent native IVC for LDLT? Transdiaphragmatic Dacron graft replacement leaving native thrombosed IVC in LDLT, surgical video presentation | Unal Aydin | ![]() |
![]() |
|||
LB eP-004 | Importance of small hepatic vein drainage (=3 mm) to prevent small for size syndrome Surgical Video Presentation | Unal Aydin | ![]() |
![]() |
|||
eP-004 | Dual Lobe liver Transplantation in a patient with renal dysfunction using a novel technique of without cross-clamping the inferior vena cava. | Sanjeev Rohatgi | ![]() |
![]() |
|||
P-004 | Piggyback versus Caval Replacement, do the kidneys pay the price? | Vivienne Hannon | ![]() |
![]() |
|||
P-005 | New assessment method: Indocyanine Green Fluorescence Imaging during Normothermic Ex Vivo Liver Perfusion for DCD graft | Toru Goto | ![]() |
![]() |
|||
eP-005 | Two techniques of anatomical graft reduction in very large for size grafts. | Rajesh Rajalingam | ![]() |
![]() |
|||
eP-006 | Standardized extrahepatic glissonean pedicle approach and liver hanging maneuverfor living donor hepatectomy | Taizo Hibi | ![]() |
![]() |
|||
P-006 | Experience with Meso-Rex bypass after segmental liver transplant for the treatment of symptomatic portal vein thrombosis | Caroline Lemoine | ![]() |
![]() |
|||
LB P-007 | Successful OR to ICU handoff for complex surgical patients: a liver transplant model experience | Nelson Gonzalez | ![]() |
![]() |
|||
P-007 | What matters is quality not quantity bile production in liver grafts on Normothermic machine perfusion | Rohit Gaurav | ![]() |
![]() |
|||
eP-007 | A novel technique of portal vein reconstruction in pediatric LDLT using transversely tansposed PV autologous graft | Shishir Pareek | ![]() |
![]() |
|||
eP-008 | Pure laparoscopic donor right hepatectomy in a living donor with anatomic variations of type 3 portal vein, type 3b bile duct, type 4b hepatic vein | Chan Woo Cho | ![]() |
![]() |
|||
P-008 | The intention-to-treat effect of bridging therapies in the setting of Milan-in patients waiting for liver transplantation | Quirino Lai | ![]() |
![]() |
|||
LB P-008 | Isoglycyrrhinate magnesium rescues biliary IRI through HMGB1 inhibition in a rat model of liver transplantation | Yuanxing Liu | ![]() |
![]() |
|||
P-009 | Predictive factors for 28-day mortality in Acute-on-Chronic Liver Failure patients admitted to the intensive care unit a case for liver transplant? | Amanda Pinter Carvalheiro da Silva Boteon | ![]() |
![]() |
|||
eP-009 | Meso-Rex Revision Using a Collateral in a Pediatric Patient With Portal Perfusion Steal Syndrome | Manuel Rodriguez-Davalos | ![]() |
![]() |
|||
eP-010 | Living donor hepatectomy in left sided gallbladder donor with portal vein and bile duct variation (Right trisegmentectomy including S5,6,7) | Kwang-Woong Lee | ![]() |
![]() |
|||
LB P-010 | Liver transplant consultant - a new title in India | Jyotsna Verma | ![]() |
![]() |
|||
P-010 | Renoportal Anastomosis in Liver Transplantation: Results from a Propensity Score-Based Outcome Analysis | Cristiano Quintini | ![]() |
![]() |
|||
P-011 | Flow Measurements in Adult Deceased Donor Liver Transplantation - Luxury or Necessity | Yee Lee Cheah | ![]() |
![]() |
|||
eP-011 | Orthotopic piggyback liver transplantation by side-to-side caval anastomosis | Xiaofeng Wu | ![]() |
![]() |
|||
LB P-011 | Recruitment maneuver in a patient with hepatopulmonary syndrome during liver transplantation surgery | yusuf colak | ![]() |
![]() |
|||
eP-012 | Pre-Implantation Splenectomy and Triple Vessel Outflow Technique in Left-lobe Living Donor Liver Transplantation | Masato Fujiki | ![]() |
![]() |
|||
P-012 | Risk Factors for Antibody-mediated Rejection after Adult ABO-incompatible Living-Donor Liver Transplantation in the Era of Rituximab Desensitization: A Single Center Experience | Tetsuya Tajima | ![]() |
![]() |
|||
P-013 | TOAD: Transplant Outcomes in Anesthesia Database. A proof of concept granular perioperative data warehouse | Rishi Kothari | ![]() |
![]() |
|||
eP-013 | No touch isolation technique for the prevention of postoperative recurrence of hepatocellular carcinoma after liver transplantation-combined with Trans-arterial Radioembolization | Jeong-Moo Lee | ![]() |
![]() |
|||
eP-014 | Liver Transplantations from Situs Inversus Donors | Jaekeun Kim | ![]() |
![]() |
|||
P-014 | Early postoperative myocardial injury is associated with perioperative cardiovascular complications after liver transplantation | Jeieung Park | ![]() |
![]() |
|||
LB P-014 | Predictors of acute kidney injury in liver transplant recipients at a single centre: a retrospective review | Steven Moore | ![]() |
![]() |
|||
LB P-015 | Use of venous conduct in grade III and IV portal vein thrombosis in liver transplantation: a single center experience from northeastern Brazil | Emmanuel Nogueira | ![]() |
![]() |
|||
P-015 | Application of goal-directed fluid therapy in fluid management after liver transplantation | Wenjing Wang | ![]() |
![]() |
|||
eP-015 | No touch left approach technique in LDLT for right advanced HCC | Gilchun Park | ![]() |
![]() |
|||
eP-016 | Ex-vivo organ perfusion technique for deceased brain death (DBD) donor | Amit Rastogi | ![]() |
![]() |
|||
P-016 | Intraoperative oliguria with decreased SvO2 predicts acute kidney injury after living donor liver transplantation | Won Ho Kim | ![]() |
![]() |
|||
LB P-016 | Diagnosis of donor derived infection by metagenomic next-generation sequencing in orthotopic liver transplantation | Junfeng Huang | ![]() |
![]() |
|||
LB P-017 | Hepatic artery and celiac trunk dissection during endovascular treatment of SASS after liver transplantation | Agnieszka Lepiesza | ![]() |
![]() |
|||
eP-017 | Robotically created jejunogastrostomy to regain endoscopic access to Roux-en-Y hepaticojejunostomy after right lobe live liver transplant | George Rofaiel | ![]() |
![]() |
|||
P-017 | Albumin dialysis with MARS in the treatment of cirrhotic patients with acute on chronic liver failure (ACLF) with a transplant perspective | Faouzi Saliba | ![]() |
![]() |
|||
eP-018 | THE first robotic left lateral sectionectomy for pediatric living donor liver transplantation AT THE KING FAISAL SPECIALIST HOSPITAL (KFSHRC), SAUDI ARABIA: description of the technique | Yasser Elsheikh | ![]() |
![]() |
|||
LB P-018 | Controlled donation after circulatory death up to 80 years for liver transplantation | Felipe Alconchel | ![]() |
![]() |
|||
P-018 | Peripheral Saphenous Venous Pressure for Monitoring Transhepatic Venous Pressure Gradient During Liver Transplantation | Wei-Lin Allen | ![]() |
![]() |
|||
LB P-019 | Failed ability to donate under donation after circulatory death protocol | Matthew Vogt | ![]() |
![]() |
|||
eP-019 | Full laparoscopic left lateral sectionectomy with graft reduction in paediatric living donor liver transplant | Yujia Gao | ![]() |
![]() |
|||
eP-020 | Removal of auxiliary liver graft: a challenging decision | Michele Tedeschi | ![]() |
![]() |
|||
P-020 | Assessment of physician performance in a liver transplant program | James Kindscher | ![]() |
![]() |
|||
LB P-020 | A case of severe abdominal infection after liver transplant caused by donor-derived carbapenem-resistant klebsiella pneumoniae | Jinyan Zhang | ![]() |
![]() |
|||
P-021 | Liver-kidney transplantation in a patient with hypertrophic obstructive cardiomyopathy (HOCM) | Nicholas Mendez | ![]() |
![]() |
|||
eP-021 | Right Trisegmentectomy With Caudate Lobectomy Combined With Portal Vein Reconstrucion For Hilar Cholangiocarcinoma | Xiangcheng Li | ![]() |
![]() |
|||
eP-022 | Extended right hemihepatectomy with anterior approach for infant hepatoblastoma | Li Xiangcheng | ![]() |
![]() |
|||
P-022 | Does Renal Resistive Index predict acute kidney injury in patients undergoing living related liver transplantation a prospective pilot study | Vijay Shankar | ![]() |
![]() |
|||
LB P-022 | Portal vein thrombosis is not a contraindication in liver transplantation | Yee Lee Cheah | ![]() |
![]() |
|||
P-023 | Does temporary portocaval shunt use during liver transplantation prevent postreperfusion syndrome? | ALEXANDRE CHEBARO | ![]() |
![]() |
|||
eP-023 | Pure laparoscopic hepatectomy in extreme anatomical variations with reference to hanging maneuver and portal vein suture technique and danger management. | Kyung-Suk Suk | ![]() |
![]() |
|||
LB P-024 | Organs donation and potential donor: knowledge of USCS medicine scholars | Soraia Damião | ![]() |
![]() |
|||
P-024 | Resolution of coagulopathy and decrease in bleeding events by day 7 after liver transplantation | Don Milliken | ![]() |
![]() |
|||
LB P-026 | Evaluations for liver transplantation in patients with class II and III obesity | Yee Lee Cheah | ![]() |
![]() |
|||
LB P-028 | The risk facotrs of mortality following liver transplantation in acute liver failure: single center experience | TEVF&304;K TOLGA SAHIN | ![]() |
![]() |
|||
P-028 | Perioperative viscoelastic assay use for coagulation monitoring among U.S. liver transplantation centers | Manny Lai | ![]() |
![]() |
|||
P-029 | Complications of peripherally inserted large-bore rapid infusion catheters for patients undergoing orthotopic liver transplantations: a review of 852 cases | Sher-Lu Pai | ![]() |
![]() |
|||
P-030 | Preoperative left ventricular systolic dysfunction in association with increased consumption of intraoperative pressor in liver transplantation | Kai Sun | ![]() |
![]() |
|||
LB P-030 | Mixed venous and arterial patch: an option for the reconstruction of the hepatic veins in the domino liver transplant | Carmen Cepeda-Franco | ![]() |
![]() |
|||
P-031 | Perioperative coronary artery disease care in liver transplantation survey | Manny Lai | ![]() |
![]() |
|||
P-032 | Severe congestive heart failure after liver transplantation | HONG FU | ![]() |
![]() |
|||
LB P-032 | Cold ischemic hepatic preservation in rabbits after static conservation in a hypothermic solution based on powdered coconut water (ACP-405) | Emmanuel Nogueira | ![]() |
![]() |
|||
P-033 | Perioperative Extracorporeal Membrane Oxygenation support for a patient with respiratory failure in liver transplantation: a case report | Xinyao Tian | ![]() |
![]() |
|||
LB P-034 | Liver transplantation offers a therapeutic possibility to unresectable Klatskin tumors | Tatiana Nicolás | ![]() |
![]() |
|||
P-035 | Effects of polymyxin B hemoperfusion in patients with septic shock after liver surgery: the pilot study | A LAN LEE | ![]() |
![]() |
|||
LB P-035 | Liver transplant for ASIA syndrome. Recurrence after trasplant and inmunosuppression therapy | José-María Álamo | ![]() |
![]() |
|||
LB P-036 | Hemostatsis in Pediatric Patients undergoing Liver Transplantation: a Prospective Cohort Study | Maureen Werner | ![]() |
![]() |
|||
P-036 | Impact of Flush Fluid Potassium Concentration on Postreperfusion Hyperkalemia and New-onset Arrhythmias in Deceased Donor Liver Transplantation | Liang Zhang | ![]() |
![]() |
|||
P-037 | Postoperative Diabetes Insipidus in Liver Transplantation - A Case Report | ASHISH MALIK | ![]() |
![]() |
|||
LB P-039 | Single center experience with biodegradable stents in treatment of refractory biliary strictures after living donor liver transplantation | sadik server | ![]() |
![]() |
|||
P-039 | Preoperative opioid use correlates with higher opioid requirements after liver transplantation | Patricia Rodriguez | ![]() |
![]() |
|||
P-040 | Catastrophic events during liver transplantation strategies for team work and organs utilization | Kumar Vivek | ![]() |
![]() |
|||
LB P-040 | Contrast-enhanced ultrasound for the evaluation of hepatic artery occlusion after liver transplantation | MADHUSUDHAN CHINTHAKINDI | ![]() |
![]() |
|||
LB P-041 | Liver transplant for heart failure in patient with Rendu-Osler-Weber syndrome. Technical problems | Álamo José-María | ![]() |
![]() |
|||
P-041 | Factors associated with immediate extubation after liver transplantation in adults | James Kindscher | ![]() |
![]() |
|||
LB P-042 | Is the body mass index a risk factor in the liver transplant recipients? | Carmen Cepeda-Franco | ![]() |
![]() |
|||
P-042 | ROTEM values vary among liver transplant recipients according to etiology of liver failure and MELD score | Elaine Boydston | ![]() |
![]() |
|||
P-043 | Change to the universal use of male FFP product and decreased mortality after FFP transfusion in liver transplant recipients | eun-kyung lee | ![]() |
![]() |
|||
LB P-044 | Primary Graft Non-function in Liver Transplantation (PNF): Can we predict ? A Single Centre Experience | Mohamed Ghazaly | ![]() |
![]() |
|||
P-044 | Does intra-operative use of albumin affect post-operative outcomes in patients undergoing living related liver transplantation - a single center experience | Vijay Shankar | ![]() |
![]() |
|||
LB P-045 | Simultaneous liver kidney transplantation from brain death and living donor :early experience in 2 cases | SeungHwan Lee | ![]() |
![]() |
|||
LB P-046 | Use of steatotic donor livers for transplantation: do they affect outcome? | Mohamed Ghazaly | ![]() |
![]() |
|||
P-046 | Hyponatremia prior to liver transplantation is not associated with post-operative encephalopathy | Daniela Kniepeiss | ![]() |
![]() |
|||
P-047 | Four wavelengths cerebral oximetry was not affected by hyperbilirubinemia | Hseyin ilksen Toprak | ![]() |
![]() |
|||
LB P-047 | Post liver transplant bony aspergillosis | Rakesh Rai | ![]() |
![]() |
|||
LB P-048 | Denovo hepatocellular cancer in a liver graft following living donor liver transplant | Rakesh Rai | ![]() |
![]() |
|||
LB P-049 | Risk factor for initial poor graft function in deceased donor liver transplantation | Sung-Won Jung | ![]() |
![]() |
|||
P-049 | Liver transplantation in cirrhotic patients in the Intensive Care Unit with acute on chronic liver failure (ACLF) | Faouzi Saliba | ![]() |
![]() |
|||
LB P-050 | Direct-antiviral agents (DAA) treatment in HCV liver transplant candidates with end-stage liver disease: correlation between clinical-virological changes and histopathological features | Federica Invernizzi | ![]() |
![]() |
|||
LB P-051 | Diamond-shaped patch technique for right hepatic vein reconstruction in living-donor liver transplant: A simple method to prevent stenosis. | Tae Beom Lee | ![]() |
![]() |
|||
LB P-052 | Monitoring phosphorylation of p70S6K to assess the efficacy of mammalian target of rapamycin inhibitors in liver transplant patients | Li Shenming | ![]() |
![]() |
|||
P-054 | Intravenous Methylene Blue versus Hydroxocobalamin as Treatment for Intraoperative Vasoplegic Syndrome in Liver Transplant Patients | Sher-Lu Pai | ![]() |
![]() |
|||
P-056 | Successful orthotopic liver transplantation in severe persistent bradycardia recipient: a case report | Aphichat Suphathamwit | ![]() |
![]() |
|||
P-058 | Changes in glutathione homeostasis during living donor hepatectomy | NEHA TANDON | ![]() |
![]() |
|||
P-060 | INTRAOPERATIVE REVERSE TAKOTSUBO CARDIOMYOPATHY IN LIVER TRANSPLANTATION AN ANESTHESIOLOGISTS NIGHTMARE | ASHISH MALIK | ![]() |
![]() |
|||
P-061 | The Tricky Triad of anemia, coagulopathy and massive fluid overload managed with intraoperative phlebotomy and hemofiltration. | Vivienne Hannon | ![]() |
![]() |
|||
P-062 | Intensivist-led deceased organ donor management | Eunmi Gil | ![]() |
![]() |
|||
P-063 | Short term outcome of liver transplant for Acute on Chronic liver failure (ACLF) ad Acute decompensation (AD): an intention to treat analysis | Claudia Iegri | ![]() |
![]() |
|||
P-068 | Remodulation of early allograft dysfunction estimation: steatosis and liver weight count | Tommaso Maria Manzia | ![]() |
![]() |
|||
P-072 | Impact of early kidney dysfunction in the incidence of major cardiovascular events after liver transplantation | Lydia Sastre | ![]() |
![]() |
|||
P-073 | MELD-Na alterations on the liver transplant waiting list and its impact on listing outcome | Gerd Silberhumer | ![]() |
![]() |
|||
P-074 | Analysis of intraoperative cardiac arrest during adult liver transplantation | James Kindscher | ![]() |
![]() |
|||
P-076 | Role of cardiac troponin T in pre-transplant renal function evaluation and its possibility as prediction marker of acute kidney injury following liver transplantation | Hideya Kamei | ![]() |
![]() |
|||
P-078 | Donor-related risk factors analysis of ischemic type biliary lesion after liver transplantation from organ donation after cardiac death: a single center experience. | Qing Yang | ![]() |
![]() |
|||
P-080 | Fatal graft-versus-host disease in liver transplantation. An analysis of UNOS registry | Shunji Nagai | ![]() |
![]() |
|||
P-081 | Liver Transplantation in patients with Sickle Cell Disease: case report and review of the Scientific Registry of Transplant Recipients | Michelle Kim | ![]() |
![]() |
|||
P-082 | Programmed diagnosis and treatment pattern for hepatic artery thrombosis after orthotopic liver transplantation- a single center experience | CHUN ZHANG | ![]() |
![]() |
|||
P-087 | Chronic kidney disease in liver transplantation - even early stage disease is associated with post operative renal replacement therapy | Jeremy Nayagam | ![]() |
![]() |
|||
P-088 | Strongyloides stercoralis hyperinfection syndrome after liver transplantation: a case report | Munique Ana Pimentel Siqueira | ![]() |
![]() |
|||
P-089 | The Role of Sarcopenia in predicting outcomes after Orthotopic Liver Transplantation. | Nicholas Marrazzo | ![]() |
![]() |
|||
P-090 | Redefining cirrhotic cardiomyopathy: a shifting paradigm | Manhal Izzy | ![]() |
![]() |
|||
P-091 | Reoperation in the early period after adult living donor liver transplantation is poor | Manuel Lim | ![]() |
![]() |
|||
P-092 | Relationship between ecocardiographic alterations and NT-proBNP plasmatic levels in cirrhotic patients | Maria Dolores Espinosa | ![]() |
![]() |
|||
P-097 | Long term co-morbidity profile and outcomes of obese recipients undergoing liver transplantation winning a battle, losing the war | Rebeca Sanabria Mateos | ![]() |
![]() |
|||
P-098 | The Clinical Course of Biliary Complications After Adult to Adult Living Donor Liver Transplantation: When Does the Achilles Heel Heal? | Noruel Gerard Salvador | ![]() |
![]() |
|||
P-100 | MICROSURGICAL BILIARY RECONSTRUCTION OF MULTIPLE BILE DUCTS REDUCE BILIARY ANASTOMOTIC COMPLICATIONS IN LIVING DONOR LIVER TRANSPLANTATION | Deniz Balci | ![]() |
![]() |
|||
P-102 | Successful Treatment of hepatic vein occlusive disease after liver transplantation using defibrotide | JE HO RYU | ![]() |
![]() |
|||
P-103 | Posttransplant Lymphoproliferative Disorder after Liver Transplantation:Report of 17 cases among 735 liver transplants in single center | Jing-Yi Liu | ![]() |
![]() |
|||
P-104 | Portal vein arterialization as a salvage procedure in hepatic artery thrombosis following LDLT | ARAVIND KIDAMBI SESHADRI | ![]() |
![]() |
|||
P-107 | Hemodynamic Changes With Autologous Flushing Of Donor Graft During Orthotopic Liver Transplantation | Nicholas Marrazzo | ![]() |
![]() |
|||
P-109 | Successful treatment for end-stage hepatic alveolar echinococcosis with ex-vivo liver resection and autologous liver transplantation: a case report | Chong Yang | ![]() |
![]() |
|||
P-111 | Effect of preoperative splenectomy on the prognosis after liver transplantation: a single center experience | Qing Yang | ![]() |
![]() |
|||
P-113 | Pure red cell aplasia(PRCA) due to mycoplasma pneumonia infection in adult recipient after liver transplantation: a case report and review of the literature | Jin Peng | ![]() |
![]() |
|||
P-116 | Post liver transplant delirium in alcoholic cirrhotic patients | Hsin Rou Liang | ![]() |
![]() |
|||
P-117 | Rescue the intimal injury of graft hepatic artery by intraoperative fluorescence vascular stenting | Wan-Yu Hung | ![]() |
![]() |
|||
P-119 | Liver transplantation for severe Portopulmonary hypertension: a report of 3 cases and literature review | xiaojie chen | ![]() |
![]() |
|||
P-120 | Incidence and predictors of Post-Transplant Diabetes Mellitus in Liver Transplantation: A systematic review and meta-analysis | Sreelakshmi Kotha | ![]() |
![]() |
|||
P-121 | The Number 5 Rule to Define Primary Non-Function Following Deceased Donor Liver Transplantation: A Single Center Experience Transplanting Liver Grafts with Severe Ischemia-Reperfusion Injury | Lucas McCormack | ![]() |
![]() |
|||
P-126 | Relationship between NT-proBNP plasmatic levels and cirrhosis ethiology in cirrhotic patients candidates to a liver transplantation | Maria Dolores Espinosa | ![]() |
![]() |
|||
P-127 | Surgical complications requiring an early relaparotomy in HIV infected liver transplanted patients: risk factors and impact on survival | umberto baccarani | ![]() |
![]() |
|||
P-132 | Extra-anatomic bypass for the treatment of a mycotic pseudoaneurism after liver transplantation for hilar cholangiocarcinoma | Laura Lladó | ![]() |
![]() |
|||
P-133 | Mucormycosis in the Liver Allograft after liver transplantation for secondary biliary cirrhosis due to bile duct injury | Catherine Parmentier-de León | ![]() |
![]() |
|||
P-135 | Analysis of risk factors of primary nonfunction after liver transplantationreport of four cases | Qinfen Xie | ![]() |
![]() |
|||
P-136 | Liver transplantation in a patient with a complex vena cava anomaly | Camila Liberato Girão | ![]() |
![]() |
|||
P-138 | Anastomosis site stenosis after portal vein reconstruction through a pparacholedocal vein in cavernous transformation of recipient portal vein: a case report | Ju Ik Moon | ![]() |
![]() |
|||
P-139 | A case of unexpected sclerosing encapsulated peritonitis in deceased donor liver transplantation | Doojin Kim | ![]() |
![]() |
|||
P-140 | Management of cytomegaloviral esophagitis after liver transplantation: from nursing care perspective | Heng Cui | ![]() |
![]() |
|||
P-141 | Neutrophil count of ascites will predict an occurrence of peritonitis after liver transplantation | Akiko Omori | ![]() |
![]() |
|||
P-143 | Recipients gender and BMI are related to early acute rejection in donation after cardiac death liver transplantation | Qiang Wei | ![]() |
![]() |
|||
P-148 | Replacing Share 15 with Share 21: Improving Parity of Liver Transplant Opportunity Without Decreasing Waitlist Outcomes | Shunji Nagai | ![]() |
![]() |
|||
P-149 | Revised allocation policy to improve utilization of split-liver grafts to lower the waitlist mortality for young children and women candidates | James Perkins | ![]() |
![]() |
|||
P-152 | Waitlist dynamics in adolescents and adult patients with below average bodyweight listed for liver transplantation, results from the Eurotransplant database | Dimitri Sneiders | ![]() |
![]() |
|||
P-161 | Liver transplantation for ALD: characteristics associated with ETOH recidivism post liver transplant | Cody Thornburgh | ![]() |
![]() |
|||
P-162 | Positive Chagas donors: continues to be a limitation? | Maria Lujan Del Bueno | ![]() |
![]() |
|||
P-165 | Potential expansion of deceased donors including anti-HCV: a population based cross-sectional study from Argentina. | Maria Margarita Anders | ![]() |
![]() |
|||
P-168 | Clinical analysis of emergency liver transplantation in patients with high MELD score | Ho Joong Choi | ![]() |
![]() |
|||
P-169 | Impact of a temporary cardiac arrest in a brain dead liver donor on liver transplantation results. | Elodie TIMSIT | ![]() |
![]() |
|||
P-170 | Orthotopic Liver Transplantation using HCV-viremic Donor Organs for HCV-nonviremic Recipients, A Single Center Experience | Rohit Nathan | ![]() |
![]() |
|||
P-171 | Liver from prostate cancer positive donors - option for recipients with higher MELD score | Michal Skalski | ![]() |
![]() |
|||
P-172 | Clinical efficacy of liver transplantation using aged liver grafts from donation after citizens death: a single center experience | Binsheng Fu | ![]() |
![]() |
|||
P-173 | The role of liver graft cold ischemia in the development of post-transplant complications | daniele dondossola | ![]() |
![]() |
|||
P-174 | Dropping off the transplant waiting list how we can do better | Ning Qi Pang | ![]() |
![]() |
|||
P-179 | ABO incompatible (ABOi) liver transplantation is a good option for salvage transplantation single center experience | Assaf Issachar | ![]() |
![]() |
|||
P-180 | Portal vein thrombosis: use of left renal vein as an option for portal inflow to the liver allografts. A single-center case series. | Igor Luna Peixoto | ![]() |
![]() |
|||
P-183 | Efficacy of whole-body FDG-PET/CT in pretransplantation evaluation of asymptomatic parotid neoplasm | Shih-min Yin | ![]() |
![]() |
|||
P-184 | Liver Retransplantation, is it still justified in the current era? | Laura Lladó | ![]() |
![]() |
|||
P-185 | Living liver donor evaluation, acceptance and rejection at a newly established liver transplant centre | Amey Sonavane | ![]() |
![]() |
|||
P-187 | Nursing care of a patient receiving liver transplantation from a situs inversus donor | Heng Cui | ![]() |
![]() |
|||
P-188 | Selection of liver graft from deceased donors using shore durometer | Sora Cha | ![]() |
![]() |
|||
P-189 | The impact of extra-anatomical hepatic artery reconstruction during living donor liver transplantation on biliary complications and graft and patient survival | Jinsoo Rhu | ![]() |
![]() |
|||
P-190 | Right Lobe vs. Left Lobe Hepatectomy for Living Donor Liver Transplantation: A Systematic Review and Meta-analysis of Donor and Recipient Outcomes | Sergio Acuna | ![]() |
![]() |
|||
P-191 | Even Extensive Portal Vein Thrombosis (PVT) Should Not Limit Access to Live Donor Liver Transplantation | mark sturdevant | ![]() |
![]() |
|||
P-192 | Intraoperative near-miss events during left liver lobe donation surgery: a potential quality-control tool to assess donor safety in living donor liver transplantation | ELIANO BONACCORS-IRIANI | ![]() |
![]() |
|||
P-196 | Comparison of postoperative outcome after pure laparoscopic and open donor right hepatectomy for adult living donor liver transplantation using propensity score analyses | Sojin Kim | ![]() |
![]() |
|||
P-197 | Long-term outcome of ABO-incompatible adult living donor liver transplantation using a single protocol over 10 years | Yuji Soejima | ![]() |
![]() |
|||
P-200 | Outcomes of liver donors with a future liver remnant less than or equal to 30: A matched-cohort study | Jesse Zuckerman | ![]() |
![]() |
|||
P-202 | Portal Hyperperfusion Syndrome after Prophylactic Ligation of Spontaneous Portosystemic Shunts During Living Donor Liver Transplantation: Analysis of Risk Factors | Jeffrey Samuel Co | ![]() |
![]() |
|||
P-203 | Minimizing donor complications. Lessons learned from 1213 consecutive living donor hepatectomies. | Itsuko Chen | ![]() |
![]() |
|||
P-206 | Good Outcomes of Living Donor Liver Transplantation (LDLT) for Autoimmune Liver Diseases (AILD): A Large Single Centre Experience | Sanjiv Saigal | ![]() |
![]() |
|||
P-209 | Pure laparoscopic versus conventional open living donor right hepatectomy using a propensity score matched analysis: Challenge to 0 of complication | Jin-Uk Choi | ![]() |
![]() |
|||
P-211 | Laparoscopic-hand assisted living donor right hepatectomy: 19 cases at a single center in USA | Paulo Martins | ![]() |
![]() |
|||
P-214 | Series of totally robotic living donor hepatectomy | Yee Lee Cheah | ![]() |
![]() |
|||
P-215 | Learning curve of laparoscopic living donor right hepatectomy: review of a single surgeons 96 laparoscopic cases | Jinsoo Rhu | ![]() |
![]() |
|||
P-217 | Impact of Frailty in Cirrhotics awaiting Liver Transplantation in LDLT setting: Preliminary Experience | SWAPNIL DHAMPALWAR | ![]() |
![]() |
|||
P-221 | Post-Operative Opioid Requirements in Living Liver Donors | Hillary Braun | ![]() |
![]() |
|||
P-223 | Clinical outcomes of living versus deceased donor liver transplantation for primary sclerosing cholangitis: A Multicenter 15 year Experience. | Omar Mousa | ![]() |
![]() |
|||
P-224 | Temporal Improvements in Graft Survival following Living Donor Liver Transplant for Patients with NASH in the United States | Rashikh Choudhury | ![]() |
![]() |
|||
P-228 | Randomized Trial between Histidine-Tryptophan-Ketoglutarate HTK and Institute of George lopez(IGL-1 perfusion solutions in Living Donor Liver TransplantationLDLT | Binoj Sivasankara Pillai Thankamony Amma | ![]() |
![]() |
|||
P-229 | Validating Controlled Attenuation Parameter (CAP) in assessment of hepatic steatosis in Living Liver donors | Mohamed Shawkat | ![]() |
![]() |
|||
P-231 | Impact of body mass index =30 on pure laparoscopic donor right hepatectomy | Suk Kyun Hong | ![]() |
![]() |
|||
P-234 | Outcomes of portal vein reconstruction with technical modifications in pediatric living donor liver transplantation for biliary atresia | Seisuke Sakamoto | ![]() |
![]() |
|||
P-236 | Assessment of the Global Practice of Living Donor Liver Transplantation: Comparison of U.S. and International Programs | Juliet Emamaullee | ![]() |
![]() |
|||
P-238 | Clinical outcome of residual liver volume and hepatic steatosis after right lobe living donor hepatectomy. | Chia-En Hsieh | ![]() |
![]() |
|||
P-240 | The outcomes of liver transplantation using the graft of Protein S-deficient living donor. | Jae-Hyung Cho | ![]() |
![]() |
|||
P-241 | Synergistic Effect of Prophylactic Shunt and Splenic Artery Ligation During Living Donor Liver Transplantation: Hitting One Bird with Two Stones | Jeffrey Samuel Co | ![]() |
![]() |
|||
P-243 | An innovative public-private-philanthropic model to fund liver transplantation (LT) in a developing country | Vikram Raut | ![]() |
![]() |
|||
P-244 | Insertion of internal stent in duct-to-duct biliary reconstruction to reduce bile duct complication in living donor liver transplantation | Ho-joong Choi | ![]() |
![]() |
|||
P-248 | Hepatic blood flow after right lobe living donor liver transplantation | Oleg Kotenko | ![]() |
![]() |
|||
P-250 | A novel reconstruction method for adjacent multiple bile duct during living donor liver transplantation; dunking with mucosal eversion technique | Joo-Dong Kim | ![]() |
![]() |
|||
P-252 | Experience of hepatic artery anastomosis in living donor liver transplantation using surgical loupe: in small volume center | kwan woo kim | ![]() |
![]() |
|||
P-253 | Impact of early postoperative high or low oxygen level on outcomes after living-donor liver transplantation :a retrospective study | Yosuke Miyachi | ![]() |
![]() |
|||
P-256 | Effects of omega-3 fatty acids on outcome after living donor right hepatectomy: a pilot study | Sanghoon Lee | ![]() |
![]() |
|||
P-257 | Living liver donor surgical complication : single center experience with 512 cases. | Dong-Lak Choi | ![]() |
![]() |
|||
P-258 | Living Donor Liver Transplantation in Septuagenarians: Better Late Than Never | Ahmed Zidan | ![]() |
![]() |
|||
P-259 | Initial Experience of Laparoscopic Living Donor Hepatectomy for Pediatric Liver Transplantation in a Southeast Asian Transplant Center | Jia Hao Law | ![]() |
![]() |
|||
P-260 | Minimal invasive living donor right hepatectomy: an experience of consecutive 114 cases by a single surgeon. | Sanghyun Kang | ![]() |
![]() |
|||
P-261 | Waterjet: An effective and Safe tissue-ive tool for Parenchymal Transection in Live Donor Liver Transplantation | Reddy Sasidhar | ![]() |
![]() |
|||
P-262 | Experience of living liver transplantation for anti-donor HLA antibody positive patients | Yoshihito Kotera | ![]() |
![]() |
|||
P-267 | Vascular anastomosis of liver retransplantation for graft failure after pediatric living donor liver transplantation | Yasuharu Onishi | ![]() |
![]() |
|||
P-268 | Early Allograft Dysfunction Does Not Predict Graft or Patient Survival in Recipients of Living Donor Liver Transplantation | Hillary Braun | ![]() |
![]() |
|||
P-271 | Robotically created jejunogastrostomy to regain endoscopic access to Roux-en-Y hepaticojejunostomy after right lobe live liver transplant | George Rofaiel | ![]() |
![]() |
|||
P-272 | Single center experience of liver transplantation for Primary Hyperoxaluria Type 1 | Takaaki Kato | ![]() |
![]() |
|||
P-274 | Living related donor liver transplantation for a large hepatocellulair carcinoma in an identical twin | Ger Koek | ![]() |
![]() |
|||
P-275 | Conjoined venoplasty using recipient umbilical portion of portal vein in type III portal vein anomaly | Yangseok Koh | ![]() |
![]() |
|||
P-276 | asymptommatic late hepatic artery thrombosis after living donor liver transplantation: a case report | Linh Ho Van | ![]() |
![]() |
|||
P-280 | Viability Testing and Transplantation of Marginal Donor Livers (VITTAL) Trial: Metabolomics of normothermically perfused livers discloses molecular signatures predictive of graft viability and postoperative outcomes | Joseph Attard | ![]() |
![]() |
|||
P-281 | Initial Report of siRNA Uptake During Normothermic and Hypothermic Liver Machine Perfusion: A Promising New Therapy | Andrew Gillooly | ![]() |
![]() |
|||
P-282 | Normothermic Ex Situ Liver Perfusion of Donation after Cardiac Death Grafts Improves Mitochondrial Function | Mamatha Bhat | ![]() |
![]() |
|||
P-283 | Viability Testing and Transplantation of Marginal Donor Livers (VITTAL) Trial Outcomes: Bile duct injury assessment during the normothermic machine perfusion of discarded livers | Richard Laing | ![]() |
![]() |
|||
P-284 | Biliary bicarbonate, pH and glucose are suitable biomarkers of biliary viability during ex situ normothermic machine perfusion of human donor livers | Otto van Leeuwen | ![]() |
![]() |
|||
P-285 | The synthesis of coagulation factors during normothermic machine perfusion of livers is impaired by ischemia in pigs and might predict graft viability | Nicholas Gilbo | ![]() |
![]() |
|||
P-290 | First Italian experience with OrganOx Metra Normotermic Machine Perfusion used on discarded extended criteria donor livers | Tommaso Maria Manzia | ![]() |
![]() |
|||
P-291 | Early and newly introduced viability criteria for liver graft evaluation during normothermic machine perfusion | Daniele dondossola | ![]() |
![]() |
|||
P-294 | The study on preservation effect of new organ preservation fluid based on tetramethylpyrazine on rat donor livers with 24 hours ex-vivo HMP | Li Haoyu | ![]() |
![]() |
|||
P-295 | Both hypothermic and normothermic perfusions fail to reduce the magnitude of cancer growth in a prolonged ischemia, donation after cardio-circulatory death liver transplant model | Graziano Oldani | ![]() |
![]() |
|||
P-302 | Pediatric Living Donor Liver Transplantation in the United States: A Retrospective Review of the National Experience | Dor Yoeli | ![]() |
![]() |
|||
P-303 | Liver Transplantation for Urea Cycle Disorders in Saudi Arabia | Ahmed Zidan | ![]() |
![]() |
|||
P-305 | Pediatric Liver Transplantation for Metabolic Disease | Li-Ying Sun | ![]() |
![]() |
|||
P-306 | PEDIATRIC REFERENCE VALUES FOR THE TOTAL PSOAS MUSCLE AREA (tPMA) | Eberhard Lurz | ![]() |
![]() |
|||
P-311 | Liver Transplantation for Tyrosinemia in the Nitisinone Era | Can Karaca | ![]() |
![]() |
|||
P-313 | Combined liver-kidney transplantation for hyperoxaluria type 1: monocentric experience in adult and pediatric recipients. | Davide Cussa | ![]() |
![]() |
|||
P-314 | Simultaneous Partial Splenectomy During Liver Transplantation in Pediatric Patients for the Prevention of Persistent Severe Hypersplenism Posttransplant | Lin Wei | ![]() |
![]() |
|||
P-315 | Reducing lateral segment grafts medially improves outcome in liver transplant for infants less than 10 kgs of weight. | Subhash Subhash | ![]() |
![]() |
|||
P-316 | Hepatic artery reconstruction with interposition of donors right gastroepiploic artery graft in pediatric living donor liver transplantation for metabolic disease | xiaojie chen | ![]() |
![]() |
|||
P-319 | Living Donor Liver Transplantation using Reduced Segment 2 Monosegment Graft in an infant | Meltem Kologlu | ![]() |
![]() |
|||
P-320 | Management of portal vein anastomotic stenosis after pediatric liver transplantation: evaluation of single center experience | Hubert van der Doef | ![]() |
![]() |
|||
P-326 | Live Donor Liver Transplantation for Type 1 Citrullinemia | Can Karaca | ![]() |
![]() |
|||
P-327 | Live Donor Liver Transplantation for Hepatoblastoma | Can Karaca | ![]() |
![]() |
|||
P-328 | The risk of arterial complication in pediatric living donor liver transplantation: Importance of the arterial blood flow intensity | Takuya Harada | ![]() |
![]() |
|||
P-330 | Early referral to transplant centers is a prognostic factor influencing outcomes of pediatric liver transplantation. | Roberta Angelico | ![]() |
![]() |
|||
P-334 | Simultaneous Anatomical Subtotal Splenectomy During Liver Transplantation for the Prevention of Persistent Severe Hypersplenism Posttransplant: A Case with 3-year Follow-up | Guang-Peng Zhou | ![]() |
![]() |
|||
P-335 | Transitional care in pediatric Liver transplantation: do we need to structure a personalized program? | Iegri Claudia | ![]() |
![]() |
|||
P-340 | Methylmalonic and Propionic Acidemia among Hospitalized Pediatric Patients: A Nationwide Report | Yi-Zhou Jiang | ![]() |
![]() |
|||
P-345 | Molecular analysis of rejection and injury in liver transplant biopsies: the INTERLIVER STUDY | Philip Halloran | ![]() |
![]() |
|||
P-349 | Markedly increased p-JNK expression is associated with increased necrosis and decreased autophagy in cholestatic liver | Say-June Kim | ![]() |
![]() |
|||
P-350 | Liver transplantation for Genotype 4 HEV related acute-on-chronic liver failure. | Kentaro Ichimura | ![]() |
![]() |
|||
P-352 | INR above measurable value of 8.7 but normal ROTEM in acute fulminant hepatic failure due to acetaminophen overdose | Manny Lai | ![]() |
![]() |
|||
P-354 | Liver transplantation for acute liver failure caused by incidental diffuse primary hepatic angiosarcoma | Dongdong Lin | ![]() |
![]() |
|||
P-357 | Towards engineering human extrahepatic bile ducts from ductal extracellular matrix and biliary organoids | Jorke Willemse | ![]() |
![]() |
|||
P-363 | Improved engraftment of human hepatocytes in immunodeficient, FAH deficient pigs | Erek Nelson | ![]() |
![]() |
|||
P-364 | The effects of liver transplantation on changes in the stool microbiome | David Victor | ![]() |
![]() |
|||
P-365 | Identification of new drug targets to prevent ischemia-induced bile duct injury using a human biliary organoid model | Floris Roos | ![]() |
![]() |
|||
P-367 | Potential mRNA and miRNA are involved in with carcinogenesis of hepatocellular carcinoma by FVII | Chih-Che Lin | ![]() |
![]() |
|||
P-368 | Energetic status change during liver graft storage and normothermic machine perfusion in rats. | daniele dondossola | ![]() |
![]() |
|||
P-371 | Role of hyperperfusion portal vein flow and ischemia in porcine liver transplantation | Alice Artus | ![]() |
![]() |
|||
P-373 | Multi-omics approach to identify up- and down-stream regulators in ischemia reperfusion injury leading to early graft dysfuntion in liver transplantation | Amamdeep Bajwa | ![]() |
![]() |
|||
P-374 | Inhibition of GSK3 protects liver against ischemia/reperfusion injury via activating AMPK-mediated autophagy | Kang He | ![]() |
![]() |
|||
P-376 | The alarmin IL-33 has a key-role in hepatic ischemia-reperfusion in a mouse model | Louise Barbier | ![]() |
![]() |
|||
P-379 | Effects of the gut-liver axis on ischaemia-mediated hepatocellular carcinoma recurrence in the mouse liver | Lorenzo Orci | ![]() |
![]() |
|||
P-380 | FK506 aggravates cobalt chloride induced HepG2 cytotoxicity | Soo Jin Na Choi | ![]() |
![]() |
|||
P-381 | Generation of induced secretome from adipose-derived stem cells specialized for disease-specific treatment: an experimental mouse model | Say-June Kim | ![]() |
![]() |
|||
P-387 | Detecting graft-derived cell-free DNA via Y-chromosome-specific-PCR andamplification-refractory-mutation-system-PCRin living-donor liver transplantation | Hoi-Ioi Ng | ![]() |
![]() |
|||
P-389 | miRNA expression profiles of FFPE liver biopsies from transplanted HCV mono-infected and HCV/HIV co-infected patients | umberto baccarani | ![]() |
![]() |
|||
P-392 | Safety of intra-operative blood salvage in hepatocellular carcinoma liver transplantation: tumor cell detection via spiral microfluidics technology | Jarrod Kah Hwee Tan | ![]() |
![]() |
|||
P-393 | Pathological interpretation and genetic polymorphisms of acute rejection associated with low serum 25-hydroxyvitamin D after living donor liver transplantation | King-Wah Chiu | ![]() |
![]() |
|||
P-397 | Potentiality of cryopreserved pig Hepatocyte spheroids for BAL system development using serum-free solutions | Sanghoon Lee | ![]() |
![]() |
|||
P-399 | Cytotoxicity of FK506 through TRAIL pathways in human Jurkat T cells | Sang Young Chung | ![]() |
![]() |
|||
P-403 | Sirtuin 1 associated to different hepatic protection outcome regarding levels of steatosis | ARNAU PANISELLO-ROSELLO | ![]() |
![]() |
|||
P-404 | FAS siRNA donor administration has the potential to alleviate ischemia-reperfusion injury in an arterialized rat liver transplant model. | ELIANO BONACCORSI-RIANI | ![]() |
![]() |
|||
P-405 | Increases in ALDH2 protein content is associated to hepatoprotection through autophagy and UPS in fatty liver cold ischemia. | ARNAU PANISELLO-ROSELLO | ![]() |
![]() |
|||
P-411 | Real-life experience with mTOR inhibitors treatment after liver transplantation | Helena Katchman | ![]() |
![]() |
|||
P-412 | MeltDose technology versus once-daily prolonged release tacrolimus in de novo liver transplant recipients | umberto baccarani | ![]() |
![]() |
|||
P-414 | Ab initio mammalian target of rapamycin inhibitors in liver transplantation: mid-term results of observational cohort study | Tommaso Maria Manzia | ![]() |
![]() |
|||
P-419 | Very early immunosuppression predicts the first-year renal function post liver transplantation | Tommaso Di Maira | ![]() |
![]() |
|||
P-420 | Could IL-2 receptor blocker be used for prolonged maintenance, calcineurin free, immunosuppression in post liver transplant recipients? | Ashokkumar Jain | ![]() |
![]() |
|||
P-425 | Squint: Unique Tacrolimus related toxicity | Ushast Dhir | ![]() |
![]() |
|||
P-427 | Mixed Chimerism following Graft versus Host Disease in a Recipient of a Liver Transplant | Ahmad Karadagi | ![]() |
![]() |
|||
P-428 | Once-daily tacrolimus is safe for pregnancy and childbirth after living donor liver transplantation (case) | Geun Hong | ![]() |
![]() |
|||
P-432 | Microfluidic chip combined with magnetic-activated cell sorting technology for tumor antigen-independent sorting of circulating hepatocellular carcinoma cells | Xue-Bin Wang | ![]() |
![]() |
|||
P-434 | Liver Transplant Outcomes for Locally Advanced Intrahepatic Cholangiocarcinoma are Comparable to Hilar Cholangiocarcinoma within Mayo Criteria: A Single Center Experience | Keri Lunsford | ![]() |
![]() |
|||
P-436 | Correlation between classification of circulating tumor cells in peripheral blood and early recurrence in patients with hepatocellular carcinoma after liver transplantation | Binsheng Fu | ![]() |
![]() |
|||
P-439 | Clinical characteristics associated with HCC in African American patients | Kapil Kohli | ![]() |
![]() |
|||
P-443 | Metroticket 2.0 validation in an Australian liver transplant cohort | Ted Stoklosa | ![]() |
![]() |
|||
P-445 | Living Donor Liver Transplantation for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis after Concurrent Chemoradiation Therapy | Lee Jae Geun | ![]() |
![]() |
|||
P-448 | Expression profile analysis of circular RNAs in early recurrence of hepatocellular carcinoma | Wangyao Li | ![]() |
![]() |
|||
P-450 | While Tumour FDG-18 PET Avidity Is A Good Prognostic Marker For Recurrence Post-LDLT In NAFLD/NASH Patients With HCC, Alpha Fetoprotein Is Not | Prashant Bhangui | ![]() |
![]() |
|||
P-452 | Does meeting the Milan Criteria at the time of recurrence of hepatocellular carcinoma after curative resection have an impact on pprognosis? | Hyo-Sin Kim | ![]() |
![]() |
|||
P-458 | Dynamic prediction formulae for HCC recurrence after living donor liver transplantation | Chih-Che Lin | ![]() |
![]() |
|||
P-460 | Mixed HCC-Cholangiocarcinoma (cHCC-CCA) - A single institution experience. | Chun Han Nigel Tan | ![]() |
![]() |
|||
P-464 | Hemochromatosis gene overexpression promotes tumor growth in hepatocellular carcinoma | Pingping DONG | ![]() |
![]() |
|||
P-468 | Effect of Child Pugh Grade on Long-Term Prognosis after Liver Transplantation for Hepatocellular Carcinoma | Guoying Wang | ![]() |
![]() |
|||
P-473 | Recurrence of Hepatocellular Carcinoma (HCC) After Liver Transplantation: Patterns and Prognostic Factors in a Single Center Experience, King Faisal Specialty Hospital and Research Center (KFSH&RC) | Yusuf Barhoom | ![]() |
![]() |
|||
P-479 | Comparison of post-embolization syndrome after hepatic artery embolization in liver cirrhotic patients versus non-cirrhotic patients | Anan Abu Rmilah | ![]() |
![]() |
|||
P-484 | Usefulness of evaluating response to neoadjuvant therapy in ion of hepatocellular carcinoma patients for liver transplantation in the era of novel criteria | Michal Grat | ![]() |
![]() |
|||
P-485 | Factors Affecting Prognosis and Outcome in Live Donor Liver Transplantation for Hepatocellular Cancer: Is There a Pattern Beyond Patient Selection Criteria? | Can Karaca | ![]() |
![]() |
|||
P-489 | Living-donor liver transplantation (LDLT) versus Deceased-donor liver transplantation (DDLT) for patients with hepatocellular carcinoma: Our 20 year experience | Koy Min Chue | ![]() |
![]() |
|||
P-494 | Sirolimus-based immunosuppression improves outcomes in liver transplantation candidates with hepatocellular carcinoma beyond the Milan criteria or the Hangzhou criteria | Sunbin Ling | ![]() |
![]() |
|||
P-498 | De novo malignancy after Liver transplantation: a single center experience | Suk-Won Suh | ![]() |
![]() |
|||
P-499 | Posttransplant lymphoproliferative disorder after liver transplantation in patients with low level of FK506 | DOND DO YOU | ![]() |
![]() |
|||
P-501 | Comparison of two eras in liver transplantation for hepatocellular carcinoma | Piotr Remiszewski | ![]() |
![]() |
|||
P-503 | Tumor recurrence treatment after liver transplantation | Ignacio M Gonzalez-Pinto | ![]() |
![]() |
|||
P-504 | Endothelial cell cytoskeleton rearrangement (ECCSKR) and endothelial to mesenchymal transition (EndoMT) in liver allografts following acute rejection (AR): its significance on the liver fibrosis | B.HANDAN Ozdemir | ![]() |
![]() |
|||
P-505 | Inflammation and Fibrosis are Observed in 34 of Clinically Stable Adult Liver Transplant Recipients | Lamia Sun | ![]() |
![]() |
|||
P-506 | Pathology of incidental hepatocellular carcinoma in explanted livers and its prognostic significance | Muthukumarassamy Rajakannu | ![]() |
![]() |
|||
P-507 | Etiology of liver dysfunction after transplantation in children with metabolic disorders | Rie Irie | ![]() |
![]() |
|||
P-508 | Simultaneous Liver and Kidney Transplant in Recurrent Acute Intermittent Porphyria | Quinton Palmer | ![]() |
![]() |
|||
P-509 | Non-invasive Machine Learning Diagnosis Model for Pancreatic Cystic Tumors Based on Pre-treatment Contrast-Enhanced CT | Fan Yang | ![]() |
![]() |
|||
P-512 | Imaging Diagnosis of Biliary Complications of ABO-Incompatibility in Living Donor Liver Transplantation | Cheng-Kang Wang | ![]() |
![]() |
|||
P-514 | Tips placement after orthotopic liver transplantation (OLT): still building the niche. Preliminary results of a single centre experience | Claudia Iegri | ![]() |
![]() |
|||
P-518 | Magnetic compression anastomosis for the treatment of biliary anastomotic stricture after orthotopic liver transplantation | Li yu | ![]() |
![]() |
|||
P-522 | A case of migration of cyanoacrylate into portal vein after living donor liver transplantation | HEE YEON KIM | ![]() |
![]() |
|||
P-523 | Associated balance of risk score comprehensive complication index for the prediction of long-term survival after liver transplantation: starting from the ABC | Samuele Iesari | ![]() |
![]() |
|||
P-524 | Life expectancy (LE) and loss-of-LE in HCC patients receiving liver transplantation versus hepatic resection | Yih-Jyh Lin | ![]() |
![]() |
|||
P-525 | Interstitial glucose metabolism in deceased donor liver allograft during the first week after transplantation - the microdialysis study | Alexander Sushkov | ![]() |
![]() |
|||
P-526 | The association of insurance coverage with outcomes of liver transplantation in the United States | Maria Stepanova | ![]() |
![]() |
|||
P-528 | Recipient Sex Interacts with Primary Diagnosis to Affect Liver Transplant Graft Survival | Dor Yoeli | ![]() |
![]() |
|||
P-529 | Liver Transplantation From Octogenarian Donors: Analysis of The European Liver Transplant Registry (ELTR) | Piotr Domagala | ![]() |
![]() |
|||
P-532 | Long-term Outcomes of Patients with Pre-tranplant Portal Vein Thrombosis After Living Donor Liver Transplantation: Experience from a High Volume Center | Chao-Long Chen | ![]() |
![]() |
|||
P-534 | The prognostic impacts of donor gender in deceased donor liver transplantation for hepatocellular carcinoma | Kazunari Sasaki | ![]() |
![]() |
|||
P-535 | Fibrinolytic shutdown is associated with thrombotic and hemorrhagic complications and poorer outcomes after liver transplantation | Ramona Nicolau-Raducu | ![]() |
![]() |
|||
P-536 | Fibrinolytic shutdown is associated with intraoperative bleeding and thrombosis during visceral transplant | Yehuda Raveh | ![]() |
![]() |
|||
P-538 | Immediate versus delayed kidney implantation in combined liver-kidney transplantation: single center, observational study | Nicholas Mendez | ![]() |
![]() |
|||
P-539 | Efficacy of telemedical interventional management in patients with liver transplantation - a pilot study | Min Tian | ![]() |
![]() |
|||
P-540 | Donor-recipient size mismatch has no impact on outcomes after deceased donor whole liver transplantation: a single center analysis | Arianna Cabrales | ![]() |
![]() |
|||
P-543 | Liver transplantation for cholestatic liver diseases in adult - a single centre experience from the Eastern world | Wing Chiu Dai | ![]() |
![]() |
|||
P-544 | Donor hepatectomy time and implantation time increase the risk of non-anastomotic biliary strictures and allograft dysfunction after liver transplantation | Nicholas Gilbo | ![]() |
![]() |
|||
P-545 | Liver retransplantation in adult recipients: analysis of the Netherlands Organ Transplant Registration (NOTR) | Kosei Takagi | ![]() |
![]() |
|||
P-546 | Impact of MELD-Na course (Delta MELD-Na) on Outcome after Liver Transplantation | Gerd Silberhumer | ![]() |
![]() |
|||
P-547 | Body composition and morbidity following orthotopic liver transplantation the value of quality over quantity | Zoltan Czigany | ![]() |
![]() |
|||
P-548 | Barriers to Medication Adherence in Individuals Post-Liver Transplant and with Chronic Liver Disease: A comparison of Paediatric and Adult Services. | Jemma Day | ![]() |
![]() |
|||
P-551 | Feasibility of Aorta after endarterectomy as Middle Hepatic Vein Reconstruction in Living Donor Liver Transplantation | Jae Hyun Kwon | ![]() |
![]() |
|||
P-553 | The influence of the timing of portal vein thrombosis diagnosis on outcome in liver transplant. | Yasuhito Iwao | ![]() |
![]() |
|||
P-555 | Positive Crossmatch Liver Kidney Transplantation: Utility of Delaying Kidney Transplantation | Shekhar Kubal | ![]() |
![]() |
|||
P-557 | Managing multiple inferior right hepatic veins in right lobe living donor liver transplantation: outcomes after bench reconstruction with a novel technique of PTFE BOAT graft | Rohan Jagat Chaudhary | ![]() |
![]() |
|||
P-558 | Liver transplantation with sovraceliac aorto-hepatic vs infrarenal revascolarization: multicentric retrospective study | Andrea Benedetti Cacciaguerra | ![]() |
![]() |
|||
P-560 | Risk factors for thrombosis and bleeding in pediatric liver transplantation in an era of routine postoperative antithrombotic therapy | Maureen Werner | ![]() |
![]() |
|||
P-561 | 20 year survival after liver transplantation and development of a risk score to predict long term survival | Johanna Bayer | ![]() |
![]() |
|||
P-562 | Standardized critical care end points for deceased organ donors improve post-transplant graft function after liver transplantation | Dieter Adelmann | ![]() |
![]() |
|||
P-566 | HIV Infection Is Not Associated with Increased Cardiovascular (CV) Risk in Liver Transplant (LT) Recipients: A Single Centre Comparative Study | Carmen Vinaixa | ![]() |
![]() |
|||
P-567 | Mastery of Self-Management Skills in Young People Post-Liver Transplant and with Chronic Liver Disease in the United Kingdom. | Jemma Day | ![]() |
![]() |
|||
P-570 | Immune monitoring of peripheral lymphocytes, HLA-DR monocytes and CD64 neutrophils in liver transplant recipients: a prospective cohort study | Quan Zhuang | ![]() |
![]() |
|||
P-574 | Predictive model of morbidity and mortality for simultaneous liver transplantation and cardiac surgery: An innovative proposal | Teresa Diago Uso | ![]() |
![]() |
|||
P-576 | Effect of WeChat-based peer education on medication compliance and quality of life in patients with liver transplantation: a pilot study | Jia Liu | ![]() |
![]() |
|||
P-578 | Decision tree analysis to stratify and quantify risk of acute cellular rejection following liver transplantation | Tomohiro Tanaka | ![]() |
![]() |
|||
P-580 | Fast track in liver transplantation: six years of a full-fledged ERAS protocol | Gonzalo P. Rodríguez Laiz | ![]() |
![]() |
|||
P-582 | Pregnancy after liver transplantation: a monocentric experience | Marco Maria Pascale | ![]() |
![]() |
|||
P-583 | Portal vein thrombosis is not a contraindication to liver transplantation | Yee Lee Cheah | ![]() |
![]() |
|||
P-584 | Impact of the MELD era in Liver Allocation in Chile: Are candidates with hepatocellular carcinomas been beneficiated due to the exception points? | Luis Antonio Díaz | ![]() |
![]() |
|||
P-585 | Renal outcome one year after living donor liver transplantation of patients with pre-transplant hepatorenal syndrome or chronic renal insufficiency | Sheng-Chih Kuo | ![]() |
![]() |
|||
P-586 | Is cell saver mandatory for liver transplantation? Report of more than 500 liver transplants without auto transfusion. | Ali Jafarian | ![]() |
![]() |
|||
P-587 | Fatal skin desquamation syndrome after diseased donor liver transplantation for HBV liver cirrhosis | Radoslav Kostadinov | ![]() |
![]() |
|||
P-589 | Outcome of Living Donor Liver transplantation for Secondary biliary cirrhosis in Adult: Single Center Experience. | Youngin Yoon | ![]() |
![]() |
|||
P-591 | Long-term outcomes of combined liver and kidney transplantation: a single center experience | Mazzola Alessandra | ![]() |
![]() |
|||
P-597 | Graft-recipient-weight ratio shows no impact on renal function improvement one year after living donor liver transplantation | Sheng-Chih Kuo | ![]() |
![]() |
|||
P-598 | Progressive Multifocal Leukoencephalopathy caused by JC-virus infection after orthotopic liver transplantation: A case report and review of the literature. | Ger Koek | ![]() |
![]() |
|||
P-601 | Management of portal vein thrombosis during liver transplantation: A single-center experience | Tae-Seok Kim | ![]() |
![]() |
|||
P-602 | Modified technique in liver procurement for deceased donor comparing outcomes and survival with conventional method | Miu Yee Chan | ![]() |
![]() |
|||
P-604 | Simplifying medications in liver or kidney transplant patients | Hyo Joo Park | ![]() |
![]() |
|||
P-606 | The reason of death for the liver transplantation recipients at a single center in China | Feiwen Deng | ![]() |
![]() |
|||
P-607 | Ischaemia Reperfusion Related Ontable Primary Graft Non Function of the Liver | Diana Bogatu | ![]() |
![]() |
|||
P-608 | The course of renal disease liver transplant recipient who requiring perioperative dialysis in liver transplantation | Dong Hoon Shin | ![]() |
![]() |
|||
P-610 | Heterozygous a 1 Antitrypsin Deficiency Z Allele is Enriched in Patients with NASH, Alcoholic Liver Disease and Cryptogenic Cirrhosis Awaiting Liver Transplantation | Anan Abu Rmilah | ![]() |
![]() |
|||
P-611 | Decline in HCV as an etiology for liver transplantation in direct acting antivirals era | Narendra S Choudhary | ![]() |
![]() |
|||
P-612 | Incidence of AKI in various etiological conditions in LDLT - experience with 1450 cases for a single centre | nikunj gupta | ![]() |
![]() |
|||
P-614 | Fibrosis-related miRNA expression profiles in end-stage liver disease candidates to liver transplantation: comparative study between Western and Eastern patients | Susumu Eguchi | ![]() |
![]() |
|||
P-615 | Outcome of hepatitis C related liver transplantation in direct acting antivirals era | Neeraj Saraf | ![]() |
![]() |
|||
P-616 | Short and Long-term outcomes of Intentional Allocation of Hepatitis C Positive Livers (even viremic donors) into Hepatitis C Negative Recipients | Paulo Martins | ![]() |
![]() |
|||
P-619 | Successfully blocking HBV transmission from an infected native liver to a graft in auxiliary liver transplantation | Li-Ying Sun | ![]() |
![]() |
|||
P-620 | Liver recipient characteristic (still) reflects general epidemiological data on HCV and HCC morbidity. Poland - country data | Jaros&322;aw Czerwi&324;ski | ![]() |
![]() |
|||
P-624 | Liver steatosis after living donor liver transplantation | nuttapon arpornsujaritkun | ![]() |
![]() |
|||
P-625 | The final effort of the hepatitis C virus (HCV) in the world of organ transplant | Assaf Issachar | ![]() |
![]() |
|||
P-627 | Management of de novo hepatitis B infection from hepatitis B core antibody-positive donors | Seong-Hwan Chang | ![]() |
![]() |
|||
P-628 | IVC clamping first and rapid implanting technique applied in liver transplantation treating complicated polycystic liver | Fangzhou Luo | ![]() |
![]() |
![]() |
Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. ![]() To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress. ![]() |
![]() |
||
![]() |
|